Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model01:14

Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model

147
The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A...
147
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

4.7K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

159
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
159
Tumor Progression02:07

Tumor Progression

6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Tumor Progression02:07

Tumor Progression

3.1K
3.1K
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

12.5K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LDB1-dependent enhancer connectivity defines T-cell leukemia identities and masks metabolic vulnerabilities.

bioRxiv : the preprint server for biology·2026
Same author

Immune evasion, infectivity, and membrane fusion of SARS-CoV-2 variants LP.8.1.1, XEC.25.1, XFG, and NB.1.8.1.

Microbiology spectrum·2026
Same author

Rhein Confers Protection Against Pneumococcal Pneumonia via Immunomodulation of the MAPK/NF-κB Axis.

Iranian journal of immunology : IJI·2026
Same author

Plasticity under pressure: biology and detection of lineage switch in acute leukemia.

Leukemia·2026
Same author

Spatially resolved T cell receptor tracking reveals γδT cell localization to tumor-rich regions in high-risk neuroblastoma: A Report from the Children's Oncology Group.

medRxiv : the preprint server for health sciences·2026
Same author

Differential cytokine architecture in patients treated with CART19 versus CART22.

Journal for immunotherapy of cancer·2026

Related Experiment Video

Updated: Apr 30, 2026

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.6K

Modeling disease progression using dynamics of pathway connectivity.

Xiaoke Ma1, Long Gao1, Kai Tan1

  • 1Department of Internal Medicine and Department of Biomedical Engineering, University of Iowa, Iowa City, IA 52242, USA.

Bioinformatics (Oxford, England)
|April 29, 2014
PubMed
Summary

We developed the M-module algorithm to analyze dynamic changes in gene pathway connectivity. This approach significantly improves disease stage prediction by revealing molecular events underlying disease progression.

More Related Videos

A Web Tool for Generating High Quality Machine-readable Biological Pathways
08:01

A Web Tool for Generating High Quality Machine-readable Biological Pathways

Published on: February 8, 2017

21.2K
JUMPn: A Streamlined Application for Protein Co-Expression Clustering and Network Analysis in Proteomics
07:28

JUMPn: A Streamlined Application for Protein Co-Expression Clustering and Network Analysis in Proteomics

Published on: October 19, 2021

2.7K

Related Experiment Videos

Last Updated: Apr 30, 2026

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.6K
A Web Tool for Generating High Quality Machine-readable Biological Pathways
08:01

A Web Tool for Generating High Quality Machine-readable Biological Pathways

Published on: February 8, 2017

21.2K
JUMPn: A Streamlined Application for Protein Co-Expression Clustering and Network Analysis in Proteomics
07:28

JUMPn: A Streamlined Application for Protein Co-Expression Clustering and Network Analysis in Proteomics

Published on: October 19, 2021

2.7K

Area of Science:

  • Systems biology
  • Computational biology
  • Genomics

Background:

  • Disease progression involves dynamic changes in molecular pathway activity and connectivity.
  • Understanding these dynamics is crucial for prognosis and treatment.
  • Molecular pathway connectivity dynamics remain underexplored compared to activity dynamics.

Purpose of the Study:

  • To introduce the M-module algorithm for identifying gene modules with dynamic connectivity across networks.
  • To develop a novel metric for quantifying M-module connectivity dynamics.
  • To investigate the properties and disease relevance of M-modules with dynamic connectivity.

Main Methods:

  • Developed the M-module algorithm to identify gene modules with varying connectivity across multiple co-expression networks.
  • Introduced a new metric to capture the connectivity dynamics of M-modules.
  • Analyzed topological and biochemical properties of dynamic versus static M-modules and hub genes.

Main Results:

  • M-modules exhibiting dynamic connectivity possess distinct topological and biochemical characteristics.
  • Incorporating module connectivity dynamics enhances disease stage prediction accuracy.
  • Identified specific M-modules associated with disease stage transitions, offering insights into progression mechanisms.

Conclusions:

  • The M-module algorithm and metric provide a novel framework for analyzing molecular pathway dynamics.
  • Dynamic connectivity analysis offers new insights into disease progression and molecular events.
  • The M-module approach is broadly applicable to studying dynamics in molecular pathways beyond disease progression.